ClinConnect ClinConnect Logo
Search / Trial NCT06909175

Comparing Portal Vein Assessment by Intraoperative Doppler and Transesophageal Echocardiography

Launched by INSTITUTE OF LIVER AND BILIARY SCIENCES, INDIA · Apr 2, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying two different methods of checking the health of a major blood vessel called the portal vein during liver transplants. The trial aims to compare a technique called transesophageal echocardiography (TEE), which involves using a special ultrasound from the esophagus, with the more traditional method of using transabdominal Doppler, which involves placing a device on the abdomen. The goal is to see which method provides better information about the portal vein during living donor liver transplants, a procedure where a portion of a healthy liver is given to someone in need.

To participate in this trial, patients must be over 18 years old and have undergone a living donor liver transplant. Unfortunately, if some necessary information isn’t available, they won't be able to join the study. The trial is not yet recruiting participants, so there will be more details to come. If you or a loved one is considering a liver transplant, this study could help improve how doctors monitor patients during surgery, potentially leading to better outcomes.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients who have undergone Live donor liver transplant, Age \> 18 years
  • Exclusion Criteria:
  • Required data is not available

About Institute Of Liver And Biliary Sciences, India

The Institute of Liver and Biliary Sciences (ILBS) in India is a premier research and healthcare institution dedicated to the advancement of knowledge and treatment in liver, biliary, and related diseases. As a clinical trial sponsor, ILBS is committed to conducting innovative and ethically-driven research to improve patient outcomes and enhance therapeutic options in hepatology. The institute fosters collaboration among multidisciplinary teams of clinicians, researchers, and healthcare professionals, ensuring rigorous scientific methodologies and adherence to regulatory standards. Through its focus on translational research, ILBS aims to bridge the gap between laboratory discoveries and clinical applications, ultimately contributing to the global understanding and management of liver diseases.

Locations

Patients applied

0 patients applied

Trial Officials

Gaurav Sindwani, MD

Principal Investigator

Institute of Liver and Biliary Sciences

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported